ArticlePharmaceuticals (Basel, Switzerland)2024

Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry.

Michihiro Suwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.